A group of MPs called for the UK government to cancel its £330 million deal with Palantir. CEO Louis Mosley labeled these demands irresponsible, claiming the move would jeopardize patient care. The dispute centers on data privacy and procurement transparency. This friction highlights the growing tension between private AI infrastructure and public health governance.